Licorice Root Market (2026 - 2036)

Licorice Root Market Size, Growth, and Forecast By FMI

The global licorice root market was valued at USD 1,130.41 million in 2026 and is projected to reach USD 2,308.22 million by 2036, expanding at a CAGR of 7.40% over the forecast period. The market’s expansion is rooted in a structural reordering of buyer qualification criteria, where defined concentration thresholds now determine extract acceptance across regulated formulation pipelines.

Licorice root has shifted from being transacted primarily as a botanical raw material to being evaluated as a controlled input within pharmaceutical, nutraceutical, cosmetic, and tobacco manufacturing systems. Medium Glycyrrhizin (10–20%) accounts for 26% of the active compound standardization segment, reflecting the commercial balance between efficacy and regulatory tolerance. Deglycyrrhizinated variants and flavonoid-rich fractions further extend usability in therapeutic categories where intake sensitivity and labelling governance are material considerations. Commercial differentiation therefore hinges on concentration discipline, assay validation capability, and batch reproducibility.

Summary of Global Licorice Root Market

• Growth Outlook (2026-2036)
  • The global licorice root market is projected to expand at a CAGR of 7.40% between 2026 and 2036.
  • Market value is expected to increase from USD 1,130.41 million in 2026 to USD 2,308.22 million by 2036.
  • Growth reflects sustained integration of licorice derivatives into pharmaceutical, nutraceutical, cosmetic, and tobacco formulation systems.
  • Expansion is concentration-governed rather than volume-driven, as buyers require defined glycyrrhizin ranges for therapeutic and labeling alignment.
  • Medium Glycyrrhizin (10–20%), representing 26% of the active compound segment, remains the dominant concentration band due to balanced performance and regulatory manageability.
• FMI Research Approach (Growth Outlook Section)
  • Forecast modeling integrates user-provided base value, forecast value, and CAGR.
  • Segment shares and country growth rates are incorporated.
  • Application allocation and extract-tier value distribution analysis support projections.
• Market Evolution Perspective (FMI Analyst View)
  • Market evolution is driven by operational discipline rather than consumer-led expansion.
  • Shift toward concentration-controlled extract manufacturing aligned with defined glycyrrhizin thresholds and DGL formats.
  • Enriched flavonoid fractions are increasingly aligned with targeted application needs.
  • Supplier defensibility depends on assay verification capability, batch-to-batch consistency, and yield optimization.
  • Extraction technology selection plays a central role in competitive positioning.
  • Aqueous and hydroalcoholic extraction systems maintain cost efficiency for mid-band concentrations.
  • Supercritical CO2 extraction supports higher-purity targeting and fraction isolation.
  • Margin structure depends on solvent recovery rates and active compound yield per metric ton.
• FMI Research Approach (Evolution Assessment)
  • Assessment incorporates user-provided segmentation across product form and application.
  • Active compound distribution and company share inputs are evaluated.
  • Structural revenue concentration analysis is applied.
• Country Leadership
  • China holds the largest share in the global licorice root market.
  • Projected CAGR of 8.40% during 2026 to 2036.
  • Leadership reflects integrated cultivation networks and established extraction infrastructure.
  • Strong downstream pharmaceutical incorporation within traditional medicine frameworks.
  • Vertical alignment across raw dried root, semi-processed extracts, and standardized ingredients strengthens export capacity.
  • Cost stability and operational resilience are supported by domestic ecosystem integration.
• FMI Research Approach (Country-Level Assessment)
  • Leadership determination is based on leading country designation and comparative CAGR inputs provided by the user.
• Market Size by 2036
  • The global licorice root market is projected to reach USD 2,308.22 million by 2036.
• FMI Research Approach (Market Size Projection)
  • Projection aligns directly with the forecast value and CAGR inputs provided by the user.
• Regulatory and Policy Influence
  • Regulatory oversight reinforces demand for documented concentration thresholds and validated extract profiles.
  • Pharmacopeial frameworks and labeling regulations require defined glycyrrhizin limits.
  • Medium-band extracts and deglycyrrhizinated (DGL) formats are increasingly preferred for controlled intake management.
  • Traceability expectations favor controlled organic cultivation and contract farming systems.
  • Procurement frameworks prioritize concentration transparency, audit readiness, and extract reproducibility.
• FMI Research Approach (Regulatory Evaluation)
  • Assessment is derived from user-provided segmentation inputs and active compound shares.
  • Cultivation structuring across the market is incorporated into regulatory evaluation.

Value creation is increasingly concentrated at the processing stage. The market spans whole root, cut and sifted root, powdered and granulated forms, paste, liquid extract, dry extract, and standardized derivatives. Whole root maintains 18.7% share within product form due to its foundational role as extraction feedstock and use in traditional medicine systems. However, incremental margin accumulation is migrating toward calibrated extract tiers. Solvent recovery efficiency, solids yield per metric ton, and concentration targeting precision directly influence cost per active unit. Technologies including aqueous, hydroalcoholic, ethanol, supercritical CO2, and spray-drying systems enable precise fraction management across industrial applications.

Demand remains anchored in regulated therapeutic applications. Cough and cold preparations account for 14.7% of application share, followed by Nutraceutical and Dietary Supplements at 12.9% and Traditional Medicine at 11.4%. These categories rely on predictable mucoprotective and anti-inflammatory functionality, reinforcing licorice derivatives as performance-critical formulation components rather than discretionary botanical inclusions.

On the supply side, the competitive landscape remains moderately fragmented. MAFCO Worldwide holds 7% market share, followed by Norevo at 5% and F&C Licorice at 4.80%, while Others collectively account for 53.20%. Competitive positioning is shaped by extraction scalability, concentration governance capability, cultivation oversight, and documentation robustness rather than brand leverage.

Regulatory enforcement of glycyrrhizin labeling and pharmacopeial concentration bands is accelerating displacement of unstandardized bulk supply. Suppliers capable of integrating cultivation, extraction, and standardized ingredient finishing are positioned to capture incremental value over the forecast horizon.

Why Is the Demand for Global Licorice Root Growing?

Demand for licorice root is expanding as regulated formulation industries increasingly require concentration-controlled botanical extracts with predictable functional outcomes. Pharmaceutical and nutraceutical manufacturers incorporate licorice derivatives into defined therapeutic applications including cough and cold preparations, gastrointestinal treatments, and anti-ulcer formulations. These categories require reliable mucoprotective and anti-inflammatory properties supported by documented concentration bands, reinforcing stable, contract-based procurement patterns.

Active compound management remains central to this demand trajectory. Medium Glycyrrhizin (10-20%) extracts account for 26% of the active compound segment, offering a balance between efficacy and regulatory tolerance. Deglycyrrhizinated licorice represents 16% share, expanding applicability in formulations where glycyrrhizin intake thresholds must be moderated. In several Western markets, glycyrrhizin exposure is monitored due to potential blood pressure implications, encouraging buyers to select controlled concentration tiers rather than unstandardized botanical inputs. Glabridin-enriched and flavonoid-rich derivatives further extend demand into dermatological and cosmetic applications where concentration variability directly influences product performance.

Processing efficiency reinforces demand expansion. Extraction systems including aqueous, hydroalcoholic, ethanol, and supercritical CO2 allow controlled concentration targeting and fraction separation. Spray-drying and resin-based systems enhance stability and shelf life while improving compatibility in finished formulations. Solvent recovery rates and yield per metric ton determine cost per active unit, influencing supplier margin structure and buyer pricing negotiations.

Cultivation strategy also introduces economic trade-offs. Wild collection can offer near-term cost advantages but introduces variability in root quality and batch consistency. Controlled cultivation and contract farming models reduce assay variability and improve documentation integrity, though often at higher unit cost. Buyers therefore segment sourcing strategies based on application criticality and regulatory exposure.

Geographically, demand growth aligns with extraction infrastructure maturity. China, expanding at 8.40%, benefits from vertically integrated cultivation and processing capacity. India at 8.10% reflects strengthening herbal formulation and nutraceutical integration. Developed markets such as the USA at 6.20% and Germany at 5.80% demonstrate stable expansion driven by regulated phytopharmaceutical demand and standardized ingredient sourcing.

Overall, demand growth in the global licorice root market is anchored in therapeutic integration, yield economics, and sourcing discipline rather than generalized botanical consumption trends.

How is the Global Licorice Root Market Segmented?

The global licorice root market is segmented by Product Form, Extract Type, Active Compound Standardization, Nature, Application, Distribution Channel, End-Use Industry, Source Species, Cultivation Method, Processing Stage, and Price Tier. Among these dimensions, Product Form, Application, and Active Compound Standardization contribute the most significant revenue concentration. These segmentation layers reflect how value is created through processing sophistication and standardization readiness, compound calibration, and end-use industry integration rather than raw botanical volume alone.

Why Does Whole Root Account for 18.7% of the Market?

18.7% of the market is accounted for by Whole Root within the Product Form segment. Whole root remains foundational due to its role in traditional medicine systems and as primary feedstock for industrial extraction facilities. It enables flexibility in downstream processing, allowing extractors to calibrate glycyrrhizin concentration based on target application.

Although higher-margin derivatives such as standardized extracts and deglycyrrhizinated formats capture premium pricing, whole root maintains relevance due to its lower initial processing cost and broad compatibility with contract extraction operations. Cultivation methods including Cultivated Farming and Wild Collection further support supply continuity. Whole root’s structural importance is therefore linked to supply chain anchoring and extraction ecosystem dependency rather than direct retail consumption.

Why Does Medium Glycyrrhizin (10-20%) Account for 26% of the Market?

26% of the market is accounted for by Medium Glycyrrhizin (10-20%) within the Active Compound Standardization segment. This concentration range offers balanced therapeutic performance while remaining within widely accepted regulatory thresholds for pharmaceutical and nutraceutical use.

Medium calibration minimizes the need for additional purification steps associated with very high glycyrrhizin enrichment, thereby optimizing yield economics and processing cost efficiency. It also aligns with major application categories including cough and cold preparations, gastrointestinal treatments, and nutraceutical supplements. As a result, this standardization tier represents the most commercially viable concentration band across diverse end-use industries, supporting consistent procurement volumes and long-term supplier contracts.

Glycyrrhizin Intake Sensitivity and Clinical Positioning Implications

Glycyrrhizin concentration management is not merely a formulation preference but a clinical constraint in several regulated markets. Excess glycyrrhizin intake has been associated with blood pressure elevation and mineralocorticoid-related sensitivity, creating regulatory and labeling scrutiny in pharmaceutical and over-the-counter categories. This sensitivity explains the structural relevance of Medium Glycyrrhizin (10-20%) extracts and Deglycyrrhizinated Licorice (DGL) formats. DGL removes glycyrrhizin while preserving flavonoid fractions and mucoprotective benefits, making it suitable for gastrointestinal and long-term therapeutic applications where intake control is critical. As regulatory enforcement intensifies around labeling transparency and concentration disclosure, buyers are increasingly segmenting procurement by therapeutic risk profile, selecting DGL or moderated concentration bands in markets where cumulative exposure may present compliance or safety concerns.

Purity Escalation vs. Yield Economics Trade-Off

Higher-purity enrichment strategies, including high glycyrrhizin concentration tiers and glabridin-focused extracts, offer performance differentiation but introduce measurable yield loss during extraction. Each additional purification stage reduces recoverable solids per metric ton of root, increasing solvent usage, processing time, and cost per standardized unit. Supercritical CO2 systems and multi-stage filtration processes improve concentration precision but may compress margin if not matched to high-value end applications. Buyers therefore balance concentration tightness against yield economics, reserving high-enrichment formats for regulated or premium-positioned products while maintaining medium-band extracts for cost-sensitive therapeutic and nutraceutical categories. Extraction efficiency now defines margin structure, as solvent recovery rates and glycyrrhizin yield per metric ton directly determine unit economics across concentration tiers.

Commodity Root Exposure Risk in an Extract-Migrating Market

As formulation industries accelerate migration toward calibrated extracts, exposure to commodity-grade raw root presents strategic risk. Whole root currently retains 18.7% share within product form, but margin migration is visibly shifting toward standardized and concentration-controlled derivatives. Buyers overly dependent on commodity-grade root face price volatility, quality variability, and reduced defensibility as pharmaceutical and nutraceutical procurement frameworks increasingly require documented assay profiles. While commodity-grade sourcing may offer short-term cost advantage, it limits participation in higher-margin extract tiers where documentation readiness define qualification. Strategic positioning therefore requires disciplined allocation between raw root exposure and value-added extract capabilities as industrial demand continues to favor standardized inputs.

Country	Country CAGR
USA	6.20%
China	8.40%
India	8.10%
Germany	5.80%
Japan	5%
UK	5.60%

Source: Future Market Insights (FMI) analysis, based on proprietary forecasting model and primary research

Why Is the USA Expanding at 6.20%?

The USA licorice root market is projected to expand at a CAGR of 6.20%, supported by structured demand from pharmaceutical companies and nutraceutical manufacturers. Deglycyrrhizinated licorice and medium-range glycyrrhizin extracts are widely incorporated into gastrointestinal and cough formulations, reinforcing repeat procurement cycles. Regulatory documentation, assay validation, and batch traceability remain central to supplier qualification. Contract manufacturers and cosmetic brands further extend demand for glabridin-enriched derivatives. The USA market demonstrates steady expansion anchored in compliance-backed sourcing rather than volume-led herbal trade.

Why Is China Growing at 8.40%?

China records the highest CAGR at 8.40%, reflecting integrated cultivation, extraction capacity, and strong domestic utilization in traditional medicine systems. Industrial extractors operate across raw dried root, semi-processed extracts, and finished standardized ingredients, supporting export and internal pharmaceutical pipelines. Growth is reinforced by vertical integration across cultivation and processing, enabling compound-level calibration at scale. China’s structural advantage lies in ecosystem depth rather than single-application dependency.

Why Is India Growing at 8.10%?

India’s licorice root market is projected to expand at 8.10%, supported by strengthening nutraceutical production and herbal formulation industries. Controlled organic cultivation and contract farming systems support export-ready standardized extracts. Pharmaceutical and traditional medicine integration contributes to stable demand. Growth reflects expanding processing sophistication and improved regulatory conformity and documentation readiness across regulated product categories.

Why Is Germany Expanding at 5.80%?

Germany’s CAGR of 5.80% reflects regulated phytopharmaceutical demand and established botanical extract processing industries. German buyers emphasize documentation, compound stability. The market is characterized by disciplined procurement rather than rapid volume expansion, reinforcing steady and predictable growth.

Why Is Japan Growing at 5%?

Japan’s 5% growth reflects incorporation of licorice derivatives within Kampo medicine and regulated therapeutic systems. Demand prioritizes standardized glycyrrhizin calibration and compliance documentation. Extraction consistency and pharmaceutical alignment support stable expansion rather than speculative botanical adoption.

Why Is the UK Growing at 5.60%?

The UK market is projected to grow at 5.60%, supported by nutraceutical integration and pharmaceutical ingredient sourcing. Procurement frameworks emphasize compound specification and traceability. Cosmetic and dietary supplement applications further contribute to moderate but stable growth.

What Strategic Moves Are Defining Competitive Landscape?

The global licorice root market demonstrates moderate fragmentation, with Others accounting for 53.20% of total market share. Among identifiable leaders, MAFCO Worldwide holds 7%, followed by Norevo at 5% and F&C Licorice at 4.80%. Competitive advantage is anchored in extraction precision, glycyrrhizin calibration capability, and vertically integrated cultivation oversight rather than consumer-facing branding.

Mid-tier players such as Sepidan Osareh Jonoob, Zagros Licorice, ASEH Licorice, and Maruzen Pharmaceuticals compete through regional extraction specialization and export orientation. Ingredient integrators including Givaudan (Naturex), Sabinsa, and Martin Bauer Group leverage broader formulation portfolios to strengthen downstream integration. Procurement leverage increasingly rests with pharmaceutical companies and nutraceutical manufacturers that require specification adherence and compliance documentation.

Strategic positioning emphasizes processing scalability, solvent recovery optimization, and batch-level traceability systems. Contract manufacturing integration and distribution alignment across B2B direct sales, bulk ingredient suppliers, and pharmaceutical ingredient distributors reinforce supplier defensibility. Competitive intensity is therefore shaped by extraction sophistication and documentation readiness rather than raw root supply access alone.

Recent Developments:

• In 2024, Norevo introduced a licorice extract range certified with Fair Trade standards to address sustainability and ethical sourcing demands in the European food and confectionery sectors.
• Also in 2024, MAFCO Worldwide launched an organic licorice extract powder tailored for the clean-label pharmaceutical segment in North America, reflecting consumer demand for plant-based natural ingredients.
• Maruzen Pharmaceuticals, in collaboration with Kosé Corporation, released a licorice-based cosmetic ingredient in Japan approved for use in skincare formulations.
• Ransom Naturals, a botanical extract producer, signed a distribution partnership with Nordmann to extend licorice extract offerings across the European market, strengthening supply networks and reach.

Key Players

• MAFCO Worldwide
• Norevo
• F&C Licorice
• Sepidan Osareh Jonoob
• Zagros Licorice
• ASEH Licorice
• Maruzen Pharmaceuticals
• Givaudan (Naturex)
• VPL Chemicals
• Sabinsa
• Botanic Healthcare
• Martin Bauer Group
• Nordmann
• Licorman
• Sunpure Extracts

Market Definition

The global licorice root market refers to the commercial cultivation, harvesting, processing, extraction, standardization, and industrial distribution of Glycyrrhiza species roots and their derivatives for use across pharmaceutical, nutraceutical, food and beverage, tobacco, cosmetic, and veterinary industries. The market encompasses raw dried root, cut and sifted formats, powdered and granulated root, flakes, paste, liquid extract, dry extract, standardized glycyrrhizin extracts, and deglycyrrhizinated licorice derivatives supplied in business-to-business channels.

At a structural level, the market is defined not merely by botanical trade volume but by active compound standardization and application-specific calibration. Glycyrrhizin concentration bands including High Glycyrrhizin above 20%, Medium Glycyrrhizin between 10% and 20%, and Low Glycyrrhizin below 10% represent critical segmentation layers within regulated pharmaceutical and nutraceutical formulation pipelines. Deglycyrrhizinated licorice, glabridin-enriched extracts, and flavonoid-rich derivatives further extend the scope into compound-specific industrial ingredient markets. Market value therefore reflects standardized extract sales rather than unprocessed botanical mass alone.

The scope includes multiple extraction technologies such as aqueous, hydroalcoholic, ethanol-based, supercritical CO2, oil-soluble, spray-dried, and resin extraction systems. It also includes semi-processed extracts, concentrated extract blocks, and finished standardized ingredients supplied to pharmaceutical companies, nutraceutical manufacturers, cosmetic and personal care brands, tobacco companies, contract manufacturers, and herbal medicine producers. Distribution channels include B2B direct sales, bulk ingredient suppliers, herbal raw material traders, pharmaceutical ingredient distributors, online bulk platforms, and finished product retail intermediaries.

The market further includes cultivation methods such as cultivated farming, wild collection, controlled organic cultivation, and contract farming systems where traceability and quality assurance affect downstream extract standardization. Price tier segmentation spans commodity grade root through standardized pharmaceutical grade, premium organic grade, and specialty extract categories such as high glabridin or DGL formats.

The market excludes finished pharmaceutical dosage forms, branded nutraceutical consumer products, alcoholic beverages, synthetic glycyrrhizin produced without botanical extraction, and products requiring reconstitution prior to consumption. It also excludes cosmetic finished goods and veterinary medicines that incorporate licorice derivatives as minor components, as market valuation reflects ingredient-level revenue rather than final product retail sales.

Overall, the global licorice root market is defined as an industrial botanical ingredient market driven by active compound calibration, processing sophistication and standardization readiness, and compliance-backed procurement rather than by consumer-packaged product branding.

Scope of Report

Items	Values
Market Name	Global Licorice Root Market
Industry Size (2026)	USD 1,130.41 Million
Industry Value (2036)	USD 2,308.22 Million
CAGR (2026-2036)	7.40%
Base Year	2026
Forecast Year	2036
Leading Country	China
Countries Covered	USA, China, India, Germany, Japan, UK
Product Form	Whole Root, Cut and Sifted Root, Powdered Root, Granulated Root, Flakes, Licorice Root Paste, Liquid Extract, Dry Extract, Standardized Extract (10%, 20%, 40% Glycyrrhizin), Deglycyrrhizinated Licorice
Extract Type	Aqueous Extract, Hydroalcoholic Extract, Ethanol Extract, Supercritical CO2 Extract, Oil-Soluble Extract, Spray-Dried Extract, Resin Extract
Active Compound Standardization	High Glycyrrhizin (>20%), Medium Glycyrrhizin (10-20%), Low Glycyrrhizin (<10%), Deglycyrrhizinated (DGL), Glabridin-Enriched Extract, Flavonoid-Rich Extract
Nature	Conventional, Organic Certified, Wild-Harvested, Sustainably Sourced / Fair Trade
Application	Cough and Cold Preparations, Gastrointestinal Treatments, Anti-Ulcer Formulations, Anti-Inflammatory Drugs, Liver Support Medicines, Hormonal Balance Therapies, Traditional Medicine (TCM, Ayurveda, Unani), Nutraceutical and Dietary Supplements, Food and Beverage, Tobacco Industry, Cosmetics and Personal Care, Animal Feed and Veterinary
Distribution Channel	B2B Direct Sales, Bulk Ingredient Suppliers, Herbal Raw Material Traders, Pharmaceutical Ingredient Distributors, Online Bulk Platforms, Retail (Pharmacies, Health Stores, E-commerce, Supermarkets)
End-Use Industry	Pharmaceutical Companies, Nutraceutical Manufacturers, Food and Beverage Manufacturers, Tobacco Companies, Cosmetic and Personal Care Brands, Contract Manufacturers (CMOs), Herbal Medicine Producers
Source Species	Glycyrrhiza glabra, Glycyrrhiza uralensis, Glycyrrhiza inflata, Other Regional Species
Cultivation Method	Cultivated Farming, Wild Collection, Controlled Organic Cultivation, Contract Farming
Processing Stage	Raw Dried Root, Semi-Processed Extract, Concentrated Extract Blocks, Finished Standardized Ingredient, Consumer Packaged Product
Price Tier	Commodity Grade, Standardized Pharmaceutical Grade, Premium Organic Grade, Specialty Extract (High Glabridin / DGL)
Key Companies Profiled	MAFCO Worldwide, Norevo, F&C Licorice, Sepidan Osareh Jonoob, Zagros Licorice, ASEH Licorice, Maruzen Pharmaceuticals, Givaudan (Naturex), VPL Chemicals, Sabinsa, Botanic Healthcare, Martin Bauer Group, Nordmann, Licorman, Sunpure Extracts

Licorice Root Market - Segmentation

By Product Form:

• Whole Root
• Cut and Sifted Root
• Powdered Root
• Granulated Root
• Flakes
• Licorice Root Paste
• Liquid Extract
• Dry Extract
• Standardized Extract (10%, 20%, 40% Glycyrrhizin)
• Deglycyrrhizinated Licorice (DGL)

By Extract Type:

• Aqueous Extract
• Hydroalcoholic Extract
• Ethanol Extract
• Supercritical CO2 Extract
• Oil-Soluble Extract
• Spray-Dried Extract
• Resin Extract

By Active Compound Standardization:

• High Glycyrrhizin Content (>20%)
• Medium Glycyrrhizin (10–20%)
• Low Glycyrrhizin (<10%)
• Deglycyrrhizinated (DGL)
• Glabridin-Enriched Extract
• Flavonoid-Rich Extract

By Nature:

• Conventional
• Organic Certified
• Wild-Harvested
• Sustainably Sourced / Fair Trade

By Application:

• Pharmaceutical Applications
  • Cough and Cold Preparations
  • Gastrointestinal Treatments
  • Anti-Ulcer Formulations
  • Anti-Inflammatory Drugs
  • Liver Support Medicines
  • Hormonal Balance Therapies
  • Traditional Medicine (TCM, Ayurveda, Unani)
• Nutraceutical and Dietary Supplements
  • Immunity Boosters
  • Digestive Health Supplements
  • Adrenal Support
  • Women's Health Supplements
  • Detox Formulations
  • Herbal Blends
• Food and Beverage
  • Confectionery
  • Herbal Teas
  • Functional Beverages
  • Flavoring Agent in Savory Foods
  • Alcoholic Beverages
  • Bakery and Traditional Sweets
• Tobacco Industry
  • Cigarette Flavoring
  • Moisture Retention Additive
  • Chewing Tobacco Blends

• Cosmetics and Personal Care
  • Skin Brightening Products
  • Anti-Acne Formulations
  • Anti-Aging Creams
  • Anti-Inflammatory Skincare
  • Scalp and Hair Care
• Animal Feed and Veterinary
  • Feed Additives
  • Gut Health Supplements

By Distribution Channel:

• B2B Direct Sales
• Bulk Ingredient Suppliers
• Herbal Raw Material Traders
• Pharmaceutical Ingredient Distributors
• Online Bulk Platforms
• Retail (Finished Product Market)
  • Pharmacies
  • Health Stores
  • E-commerce
  • Supermarkets

By End-Use Industry:

• Pharmaceutical Companies
• Nutraceutical Manufacturers
• Food and Beverage Manufacturers
• Tobacco Companies
• Cosmetic and Personal Care Brands
• Contract Manufacturers (CMOs)
• Herbal Medicine Producers

By Source Species:

• Glycyrrhiza glabra (European / Mediterranean)
• Glycyrrhiza uralensis (Chinese Licorice)
• Glycyrrhiza inflata
• Other Regional Species

By Cultivation Method:

• Cultivated Farming
• Wild Collection
• Controlled Organic Cultivation
• Contract Farming

By Processing Stage:

• Raw Dried Root
• Semi-Processed Extract
• Concentrated Extract Blocks
• Finished Standardized Ingredient
• Consumer Packaged Product

By Price Tier:

• Commodity Grade
• Standardized Pharmaceutical Grade
• Premium Organic Grade
• Specialty Extract (High Glabridin / DGL)

By Region:

• North America
• Europe
• East Asia
• South Asia and Pacific
• Middle East and Africa

Bibliography

Botanical and Herbal Ingredient Regulatory Authorities

• USA Food and Drug Administration (FDA) - Botanical Drug Development Guidance; Dietary Supplement Health and Education Act (DSHEA); Current Good Manufacturing Practice (21 CFR Part 111); Food Additive Regulations
• USA Department of Agriculture (USDA) - National Organic Program (NOP); Organic Certification Standards for Botanical Raw Materials
• European Medicines Agency (EMA) - Committee on Herbal Medicinal Products (HMPC) Monographs; Traditional Herbal Medicinal Product Directive
• European Food Safety Authority (EFSA) - Scientific Opinions on Botanicals and Active Plant Compounds; Food Additive and Flavoring Regulations
• UK Food Standards Agency (FSA) - Botanical Ingredient Compliance and Supplement Labeling Regulations
• Health Canada - Natural Health Products Directorate (NHPD); Herbal Ingredient Monographs
• Japan Ministry of Health, Labour and Welfare (MHLW) - Kampo Medicine Standards; Functional Food Labeling Framework
• China National Medical Products Administration (NMPA) - Traditional Chinese Medicine Standards; Botanical Extract Compliance Requirements

Core EU Regulations Relevant to Botanical Extracts

• Regulation (EC) No 178/2002 - General Food Law
• Regulation (EC) No 852/2004 - Food Hygiene
• Regulation (EU) No 1169/2011 - Food Information to Consumers
• Regulation (EC) No 1924/2006 - Nutrition and Health Claims
• Regulation (EU) 2015/2283 - Novel Foods
• Regulation (EC) No 1333/2008 - Food Additives
• Regulation (EC) No 1334/2008 - Flavorings

International Standards and Codes

• Codex Alimentarius Commission (FAO/WHO) - Standards for Botanical Extracts and Food Additives; Maximum Residue Limits
• ISO 22000 - Food Safety Management Systems
• ISO 9001 - Quality Management Systems
• Hazard Analysis and Critical Control Points (HACCP) - Food Safety Risk Management
• Good Agricultural and Collection Practices (GACP) for Medicinal Plants - WHO Guidelines

Trade and Statistical Portals

• UN Comtrade Database - HS Code 1211 (Plants and Parts Used Primarily in Pharmacy); HS Code 1302 (Vegetable Extracts)
• International Trade Centre (ITC) Trade Map - Global Botanical Extract Trade Flows
• Eurostat (COMEXT) - EU Trade Database for Botanical Ingredients
• USA International Trade Commission (USITC) DataWeb - Import and Export Statistics
• World Customs Organization (WCO) - Harmonized System Classification for Medicinal Plant Extracts
• World Bank World Development Indicators - Agricultural Production and Trade Indicators